Revlimid
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Revlimid in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Revlimid.
19
Global Revenue Ranking
Recent articles on PMLiVE featuring Revlimid
With revenues for the third quarter up by 10%, BMS hopes growth for Opdivo, Eliquis and new launches will offset inevitable generic competition for Revlimid
In Q2, BMS’ revenue came in at $11.7bn, a 16% increase on the same period last year
Multiple myeloma is the second most common blood cancer
Darzalex treatment regimen reduced risk of death by 32% after nearly five years follow-up
Myeloma med approved in combination with Amgen’s Kyprolis
Sales of immunotherapy Opdivo decreased due to COVID-19 impact
Monthly meeting held remotely for the first time due to COVID-19 pandemic
Combination regimen didn’t improve progression-free survival
First cancer drug wholly owned by company to be approved in past decade
New ‘chemotherapy-free’ treatment for patients with limited options
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020
Expands use of anti-CD38 antibody even further
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology